Adenosine A1 receptor-mediated inhibition of cyclic AMP accumulation in type-2 but not type-1 rat astrocytes

European Journal of Pharmacology

Volumn 306, Issue 1-3, 1996, Pages 281-289

  Peakman, Marie Claire ^a,b   Hill, Stephen J ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b YALE UNIVERSITY   (United States)

Author keywords

adenosine receptor; astrocyte, rat; cAMP accumulation

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR AFFECTING AGENT; ADENYLATE CYCLASE; CYCLIC AMP; FORSKOLIN; ISOPRENALINE; N [2 (DIMETHYLAMINO)ETHYL] N METHYL 4 (1,3 DIPROPYLXANTHIN 8 YL)BENZENESULFONAMIDE; RADIOISOTOPE; RECEPTOR SUBTYPE; ROLIPRAM; ADENOSINE; ADENOSINE RECEPTOR; DRUG DERIVATIVE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL SPECIFICITY; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG ANTAGONISM; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; ANALYSIS OF VARIANCE; ANIMAL; CYTOLOGY; DOSE RESPONSE; DRUG POTENTIATION; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; CELLS, CULTURED; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOHISTOCHEMISTRY; RATS; RECEPTORS, PURINERGIC P1;

EID: 0030582060     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00202-6     Document Type: Article

References (39)

1. 2 adenosine receptor-induced cyclic AMP generation in cerebral cortex and relaxation of pre-contracted aorta, Br. J. Pharmacol. 111, 185.
2. Baba, A., H. Saga and H. Hashimoto, 1993, Inhibitory glutamate response on cyclic AMP formation in cultured astrocytes, Neurosci. Lett. 149, 182.
3. 3H]-NECA in rat striatal membranes, Mol. Pharmacol. 29, 331.
4. 2-receptors, Naunyn-Schmiedeberg's Arch. Pharmacol. 335, 64.
5. Bruns, R.F., G.H. Lu and T.A. Pugsley, 1987b, Adenosine receptor subtypes: binding studies, in: Topics and Perspectives in Adenosine Research, eds. E. Gerlach and B.F. Becher (Springer-Verlag, Berlin) p. 59.
6. Collis, M.G. and S.M.O. Hourani, 1993, Adenosine receptor subtypes, Trends Pharmacol. Sci. 14, 360.
7. Delapp, N.W. and K. Eckols, 1992, Forskolin stimulation of cyclic AMP accumulation in rat brain cortex slices is markedly enhanced by endogenous adenosine, J. Neurochem. 58, 237.
8. Donaldson, J., A.M. Brown and S.J. Hill, 1988, Influence of rolipram on the cyclic 3′5′,-adenosine monophosphate response to histamine and adenosine in slices of guinea-pig cerebral cortex, Biochem. Pharmacol. 37, 715.
9. Ebersolt, C., M. Perez and J. Bockaert, 1981a, Neuronal, glial and meningial localizations of neurotransmitter-sensitive adenylate cyclase in cerebral cortex of mice, Brain Res. 213, 139.
10. 2-adrenergic-sensitive adenylate cyclase of meningial cells, Brain Res. 213, 151.
11. Fern, R., S.G. Waxman and B.R. Ransom, 1991, Modulation of anoxic injury in CNS white matter by adenosine and interaction between adenosine and GABA, J. Neurophysiol, 72, 2609.
12. Fredholm, B.B., M.P. Abbracchio, G. Burnstock, J.W. Daly, T.K. Harden, K.A. Jacobson, P. Leff and M. Williams, 1994, VI International Union of pharmacology nomenclature and classification of purinoceptors, Pharmacol. Rev. 46, 143.
13. 1-receptors on astrocytes in primary cultures: A possible target for histaminergic neurones, in: New Perspectives in Histamine Research, eds. H. Timmerman and H. van der Goot, AAS 33 (Birkhauser Verlag, Basel) p. 161.
14. 2 selective adenosine receptor agonist with preferential hypotensive activity, J. Pharmacol. Exp. Ther. 251, 47.
15. 2 receptors in rat brain, J. Pharmacol. Exp. Ther. 251, 888.
16. Kondou, H., N. Inagaki, H. Fukui, Y. Koyama, A. Kanamura and H. Wada, 1991, Histamine-induced inositol phosphate accumulation in type-2 astrocytes, Biochem. Biophys. Res. Commun. 177, 734.
17. Kubo, A., H. Fukui, N. Inagaki, A. Kanamura and H. Wada, 1991, Histamine-induced cyclic AMP accumulation in type-1 and type-2 astrocytes in primary culture, Eur. J. Pharmacol. 208, 249.
18. Lazareno, S. and F.F. Roberts, 1987, Measuring muscarinic antagonist potency using phosphoinositide breakdown in rat cortex slices, Br. J. Pharmacol. 92, 677P.
19. Levison, S.W. and K.D. McCarthy, 1991, Characterization and partial purification of AIM: A plasma protein that induces rat cerebral type 2 astroglia from bipotential glial progenitors, J. Neurochem. 57, 782.
20. 1 adenosine receptors, Naunyn-Schmiedeberg's Arch. Pharmacol. 336, 204.
21. 1 adenosine receptors, Naunyn-Schmiedeberg's Arch. Pharmacol. 337, 687.
22. 2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum, J. Pharmacol. Exp. Ther. 252, 1134.
23. McCarthy, K.D. and J. De Vellis, 1980, Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue, J. Cell Biol. 85, 890.
24. McCarthy, K.D. and A.K. Salm, 1991, Pharmacologically distinct subsets of astroglia can be identified by their calcium response to neuroligands, Neuroscience 41, 325.
25. Murphy, S., 1993, Astrocytes: Pharmacology and Functions (Academic Press, New York).
26. Murphy, M.G., C.M. Moak, Z. Byczko and W.F. Macdonald, 1991, Adenosine-dependent regulation of cyclic AMP accumulation in primary cultures of rat astrocytes and neurons, J. Neurosci. Res. 30, 631.
27. Offermanns, S. and G. Schultz, 1994, Complex information processing by the transmembrane signaling system involving G proteins, Naunyn-Schmiedeberg's Arch. Pharmaol. 350, 329.
28. 2B-receptor-mediated cyclic AMP accumulation in primary rat astrocytes, Br. J. Pharmacol. 111, 191.
29. 1 receptor-mediated changes in basal and histamine-stimulated levels of intracellular calcium in primary rat astrocytes, Br. J. Pharmacol. 115, 801.
30. Raff, M.C., R. Mirsky, K.L. Fields, R.P. Lisak, S.H. Dorfan, D.H. Silberberg, N.A. Gregson, S. Liebowitz and M.C. Kennedy, 1978, Galactocerebroside is a specific cell surface antigenic marker for oligodendrocytes in culture, Nature 274, 813.
31. Raff, M.C., R.H. Miller and M. Noble, 1983, A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium, Nature 303, 390.
32. Raff, M.C., B.P. Williams and R.H. Miller, 1984 The in vitro differentiation of a bipotential glial progenitor cell, EMBO J. 3, 1857.
33. Ransom, B.R., P.K. Stys and S.G. Waxman, 1990, The pathophysiology of anoxic injury in central nervous system white matter, Stroke, 21 (suppl. 3), III52.
34. Ruck, A., D.A. Kendall and S.J. Hill, 1991, α-and β-adrenoceptor regulation of cyclic AMP accumulation in cultured rat astrocytes: A comparison of primary protoplasmic and mixed fibrous/protoplasmic astroglial cultures, Biochem. Pharmacol. 42, 59.
35. Rudolphi, K.A., P. Schubert, F.E. Parkinson and B.B. Fredholm, 1992, Neuroprotective role of adenosine in cerebral ischemia, Trends Pharmacol. Sci. 13, 439.
36. Stiles, G.L., 1992, Adenosine receptors, J. Biol. Chem. 267, 6451.
37. Van Calker, D., M. Muller and B. Hamprecht, 1979, Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells, J. Neurochem. 33, 999.
38. Witkin, G.P., D.R. Marriott and A.J. Cholewinski, 1990, Astrocyte heterogeneity, Trends Neurol. Sci. 13, 43.
39. Woods, M.D., R.I. Freshney, G. Pilkington and P.F. Vaughan, 1988, Expression of receptors linked to cyclic AMP formation by cultures of human foetal astrocytes., Biochem. Soc. Trans. 16, 432.